New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 14, 2013
07:06 EDTINCYIncyte upgraded to Buy from Neutral at Lazard Capital
Lazard Capital upgraded Incyte with a $25 price target citing increased penetration estimates for Jakafi in myelofibrosi.
News For INCY From The Last 14 Days
Check below for free stories on INCY the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
There are no results for INCY

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use